Cargando…
Can hypothyroidism be a protective factor for hepatocellular carcinoma in cirrhosis?
Despite many studies, the molecular mechanisms of hepatocellular carcinoma (HCC) development remain unclear. Thyroid hormone (TH) levels may vary in many chronic diseases including cirrhosis. The aim of this study was to evaluate TH status in patients with cirrhosis and HCC and to investigate the re...
Autores principales: | Sahin, Tolga, Oral, Alihan, Turker, Fatih, Kocak, Erdem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440066/ https://www.ncbi.nlm.nih.gov/pubmed/32176089 http://dx.doi.org/10.1097/MD.0000000000019492 |
Ejemplares similares
-
Evaluation of Predisposing Metabolic Risk Factors for Portopulmonary Hypertension in Patients with NASH Cirrhosis
por: Türker, Fatih, et al.
Publicado: (2022) -
Evaluation of Plateletcrit and Platelet Distribution Width in Patients with Non-Alcoholic Fatty Liver Disease: A Retrospective Chart Review Study
por: Oral, Alihan, et al.
Publicado: (2019) -
Relationship between Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease in Non-Obese Patients
por: Oral, Alihan, et al.
Publicado: (2019) -
Does the FT3-to-FT4 ratio easily predict the progression of NAFLD and NASH cirrhosis?
por: Türker, Fatih, et al.
Publicado: (2021) -
Prognostic role of ABO blood group and Rhesus factor in cirrhotic patients with hepatocellular carcinoma
por: Oral, Alihan, et al.
Publicado: (2019)